Two controlled clinical trials have demonstrated that MBCT can reduce the likelihood of relapse by about 40-50% in people who have suffered three or more previous episodes of depression. As a result of such findings, MBCT has now been included in the British government’s national guidelines for treating recurrent major depression.
两次控制临床试验表明：正念认知疗法可以使抑郁发作过三次或者以上患者的再次复发率降低约40-50%。这项研究的结果使正念认知疗法被纳入了英国政府治疗抑郁复发的国家指导纲要之中。